Rob Romanelli (he/him) is a research leader at RAND Europe focusing on health and well-being. Romanelli's work has focused on evaluating health care system policies, programs, and interventions designed to improve the quality and safety of care delivery. He is broadly interested in the intersection of health care delivery, health policy, public health, and health equity.
Romanelli has more than 10 years’ experience working with diverse research partners and clients ranging from U.S. federal agencies, not-for-profit organizations, and the pharmaceutical industry. His research has leveraged quantitative and qualitative methods, including systematic and scoping literature reviews, retrospective database analyses, interviews, surveys, and key-stakeholder engagement activities, to synthesize evidence and inform policy decisions. He holds a Ph.D. in biomedical sciences from the Pennsylvania State University College of Medicine and an M.P.H. from the Johns Hopkins University School of Public Health.
Romanelli RJ, Azar KMJ, S Sudat, Hung D, Frosch D, Pressman AR, "The Learning Health System in Crisis: Lessons from the Novel Coronavirus Disease Pandemic," Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 5(1), 2021
Azar KMJ, Shen Z, Romanelli RJ, Robinson S, Brown S, Smits K, Lockhart SH, Pressman AR, "Disparities in Outcomes among COVID-19 Patients in a Large Health Care System in California," Health Affairs, 39(7), 2020
Segal JB, Onasanya O, Daubresse M, Lee CY, Moechtar M, Pu X, Sutcher SK, Romanelli RJ, "Determinants of Generic Drug Substitution in the United States," Therapeutic Innovation & Regulatory Science, 54(1), 2020
Chung S, Huang Q, LaMori L, Doshi L, Romanelli RJ., "Patient-Reported Experiences in Discussing Prescribed Medications with a Health Care Provider: Evidence for Racial/Ethnic Disparities in a Large Health Care Delivery System," Population Health Management, 23(1), 2020
Marcum ZA, Huang HC, Romanelli RJ, "Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein Cholesterol: A Cohort Study of Incident Statin Users," Journal of General Internal Medicine, 34(11), 2019